Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lyra Therapeutics, Inc. | SVP of Commercial Strategy and Market Development | Common Stock | 36.7K | $109K | $2.96 | Jan 31, 2023 | Direct |
Lyra Therapeutics, Inc. | SVP of Commercial Strategy and Market Development | Stock Option | 55K | Jan 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LYRA | Lyra Therapeutics, Inc. | Jan 31, 2023 | 2 | $0 | 4 | Feb 2, 2023 | SVP of Commercial Strategy and Market Development |
LYRA | Lyra Therapeutics, Inc. | Feb 12, 2022 | 1 | $0 | 4 | Feb 15, 2022 | SVP of Commercial Strategy and Market Development Exhibit 24 - Power of Attorney |